OncoCyte Corp (OCX)
2.67
-0.08
(-2.91%)
USD |
NASDAQ |
Nov 21, 16:00
2.65
-0.02
(-0.75%)
After-Hours: 20:00
OncoCyte Price: 2.67 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 21, 2024 | 2.80 | 2.80 | 2.56 | 2.67 | 11330.00 |
| Nov 20, 2024 | 2.50 | 2.78 | 2.50 | 2.75 | 25364.00 |
| Nov 19, 2024 | 2.66 | 2.76 | 2.526 | 2.55 | 26929.00 |
| Nov 18, 2024 | 2.67 | 2.69 | 2.63 | 2.63 | 6695.00 |
| Nov 15, 2024 | 2.74 | 2.79 | 2.60 | 2.61 | 57289.00 |
| Nov 14, 2024 | 2.94 | 2.988 | 2.70 | 2.80 | 702100.0 |
| Nov 13, 2024 | 3.00 | 3.00 | 2.810 | 2.94 | 30737.00 |
| Nov 12, 2024 | 2.94 | 3.04 | 2.91 | 3.00 | 155024.0 |
| Nov 11, 2024 | 2.80 | 2.95 | 2.79 | 2.90 | 25345.00 |
| Nov 08, 2024 | 2.81 | 2.91 | 2.725 | 2.86 | 20950.00 |
| Nov 07, 2024 | 2.875 | 2.90 | 2.82 | 2.84 | 11074.00 |
| Nov 06, 2024 | 2.90 | 2.92 | 2.75 | 2.84 | 29621.00 |
| Nov 05, 2024 | 2.925 | 2.96 | 2.85 | 2.92 | 21624.00 |
| Nov 04, 2024 | 2.96 | 2.96 | 2.885 | 2.90 | 21566.00 |
| Nov 01, 2024 | 3.01 | 3.04 | 2.900 | 3.00 | 27219.00 |
| Oct 31, 2024 | 3.006 | 3.068 | 2.988 | 3.03 | 10964.00 |
| Oct 30, 2024 | 3.000 | 3.08 | 2.997 | 3.02 | 3973.00 |
| Oct 29, 2024 | 3.08 | 3.11 | 3.02 | 3.10 | 19996.00 |
| Oct 28, 2024 | 3.095 | 3.16 | 3.00 | 3.10 | 35663.00 |
| Oct 25, 2024 | 3.021 | 3.13 | 3.021 | 3.04 | 2477.00 |
| Oct 24, 2024 | 3.20 | 3.20 | 3.04 | 3.05 | 62853.00 |
| Oct 23, 2024 | 3.07 | 3.15 | 3.04 | 3.15 | 19164.00 |
| Oct 22, 2024 | 3.13 | 3.13 | 3.04 | 3.08 | 11307.00 |
| Oct 21, 2024 | 3.20 | 3.20 | 3.04 | 3.12 | 11316.00 |
| Oct 18, 2024 | 2.99 | 3.150 | 2.99 | 3.13 | 10337.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.08
Minimum
Nov 08 2023
130.00
Maximum
Feb 16 2021
31.85
Average
22.40
Median
May 19 2022
Price Benchmarks
| Fonar Corp | 16.45 |
| XWELL Inc | 1.447 |
| ProPhase Labs Inc | 0.7769 |
| Applied DNA Sciences Inc | 0.1583 |
| Veracyte Inc | 38.94 |
Price Related Metrics
| PS Ratio | 40.59 |
| Price to Book Value | 4.629 |
| Earnings Yield | -170.0% |
| Market Cap | 44.95M |